ClinicalTrials.gg
CompletedNCT05231681Updated May 6, 2022

Study to Identify if Saie Beauty's Under Eye Concealer Works to Improve Under-Eye Skin Appearance and Reduce Imperfections

An interventional study of Saie Beauty's Hydrabeam Sheer Brightening Under Eye Concealer in Wrinkle, sponsored by Saie Beauty. Completed at 1 site in United States. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-06.

Sponsored by Saie Beauty · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

Saie Beauty has developed 'Hydrabeam Sheer Brightening Under Eye Concealer' that is specifically designed for improving under-eye skin health. The concealer is aimed at improving under-eye skin features including hydration, firmness/elasticity, smoothness, and brightness. At the same time, it is aimed at reducing imperfections such as dark circles, skin redness, fine lines, wrinkles, and crow's feet. The aim is to understand and assess the efficacy of treatment from the participants' perspective and to see if the participants reported changes in skin features, dark circles, brightness, fine lines, wrinkles, crow's feet, and other skin imperfections.

02

Conditions studied

  • Wrinkle

Keywords

  • skin aging
  • fine lines
  • crow's feet
  • dark circles
03

In context

Lead sponsor

Saie Beauty is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female between 18 and 45 years old
  • Must be in good general health
  • Want to improve under-eye skin health by improving skin hydration, firmness/elasticity, smoothness, and brightness
  • May have dark circles, fine lines, wrinkles, and crow's feet
  • Must be willing to comply with the study protocol
  • Must be willing to add the concealer to their daily routine for the duration of the study
  • Must maintain a basic skincare routine, e.g., must use moisturizer and sunscreen daily
  • Able to communicate in English
  • Must provide a written Form (ICF)
  • Willing to share feedback via the given online portal

Exclusion criteria

Exclusion Criteria:

  • Unwilling to follow the routine of the study
  • Unwilling to provide
  • Currently participating in another research study
  • Severe chronic conditions including ontological and psychiatric conditions
  • Use of prescription medication relevant for the skin
  • Have any known allergies to the ingredients of the test product
  • Known to have any severe allergic reactions in the past
  • Undergoing any cosmetic procedures such as laser treatments, Botox, or chemical peels for the duration of the study.
  • Have diagnosed or self-identified sensitive skin
  • Have any learning and/or cognitive difficulties that prevent them from reading and understanding questionnaires and surveys (e.g. dementia)
  • Currently pregnant or breastfeeding, or want to become pregnant for the duration of the study
  • Use of prescription drugs (topical or oral) that are targeted at any sort of skin condition (for example retinoids)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Eye Concealer

    Saie Beauty's Hydrabeam Sheer Brightening Under Eye Concealer

    Dietary Supplement: Saie Beauty's Hydrabeam Sheer Brightening Under Eye Concealer

Interventions

  • Dietary supplementSaie Beauty's Hydrabeam Sheer Brightening Under Eye Concealer

    Eye Concealer

06

What researchers measure

Primary outcomes

  1. Skin aging [Time frame: Baseline to 4 weeks]

    Patient reported outcome measures (Scale 0-5 with higher scores representing a better outcome) to assess the reduction of early signs of aging such as fine lines, dark spots, and brighter skin

    Time frame: 4 weeks

07

Study locations

1 site
  • Citruslabs
    Santa Monica, California 90404, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2022 to primary completion in May 2022, 2 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 31, 2022
First posted
Feb 9, 2022
StartActual
Feb 15, 2022
Primary completionActual
May 1, 2022
CompletionActual
May 1, 2022
Last update
May 6, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05231681
Lead sponsor
Saie Beauty
Responsible party
Sponsor
First posted
Feb 9, 2022
Start date
Feb 15, 2022
Primary completion
May 1, 2022
Completion
May 1, 2022
Last update
May 6, 2022

Study contacts

Susanne Mitschke
principal investigator · Citruslabs

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion